Versor Investments’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,000
| Closed | -$305K | – | 748 |
|
|
2024
Q4 | $305K | Buy |
+47,000
| New | +$305K | 0.05% | 557 |
|
|
2024
Q3 | – | Sell |
-22,400
| Closed | -$125K | – | 798 |
|
|
2024
Q2 | $125K | Sell |
22,400
-24,500
| -52% | -$137K | 0.02% | 684 |
|
|
2024
Q1 | $315K | Buy |
+46,900
| New | +$315K | 0.06% | 483 |
|
|
2023
Q4 | – | Sell |
-33,900
| Closed | -$187K | – | 733 |
|
|
2023
Q3 | $187K | Buy |
+33,900
| New | +$187K | 0.04% | 597 |
|
|
2023
Q2 | – | Sell |
-12,100
| Closed | -$111K | – | 668 |
|
|
2023
Q1 | $111K | Sell |
12,100
-5,300
| -30% | -$48.7K | 0.01% | 675 |
|
|
2022
Q4 | $178K | Buy |
+17,400
| New | +$178K | 0.02% | 653 |
|